The execution gap: Why 63% of corporate strategy value never materializes

ZoomInfo reports that 63% of corporate strategy value doesn't materialize due to execution gaps, costing $2 trillion in lost ...

Samjong KPMG: "Gap Between Leading and Early-Stage Groups in ESG Disclosure and Assurance Doubles"

This year’s global ESG (Environmental, Social, and Governance) Preparedness Index survey revealed that the gap between ...

RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties

Dear Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties : As we prepare to end 2025, we would like to provide you with this open letter summarizing our ...
Managed Healthcare Executive

Relmada Therapeutics appoints Max Kates to clinical advisory board to support NDV-01 phase 3 program for bladder cancer

Relmada Therapeutics is advancing NDV-01, a novel intravesical therapy for NMIBC, into phase 3 clinical trials, with Max ...
Gulf Times

Qatar's rights action plan stresses values of human dignity

The first consultative session to prepare the National Human Rights Action Plan (2026-2030) convened in Doha Sunday.The ...
The Peninsula Qatar

First consultative session to prepare National Human Rights Action Plan convenes in Doha

The first consultative session to prepare the National Human Rights Action Plan (2026 2030) convened in Doha Sunday. The session was ...

MediWound Ltd. (NASDAQ:MDWD) Q3 2025 Earnings Call Transcript

MediWound Ltd. (NASDAQ: MDWD) Q3 2025 Earnings Call Transcript November 20, 2025 MediWound Ltd. beats earnings expectations.

RespireRx Pharmaceuticals Inc. Announces SEC Order Making Findings and Revoking Registration of Securities and Future Plans with respect to its Common Stock

On November 13, 2025, effective November 14, 2025 the Securities and Exchange Commission (“Commission”), in Administrative Proceeding File No. 3-22541, in Release No. 104178 issued an Order Making ...
PharmExec

Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers

The first wave of Commissioner’s National Priority Vouchers signals a fundamental shift in FDA competitiveness, rewarding companies that pair breakthrough science with affordability commitments, ...

GSK plc (GSK) Presents at Jefferies London Healthcare Conference 2025 Transcript

Jefferies London Healthcare Conference 2025 November 19, 2025 4:30 AM ESTCompany ParticipantsTony Wood - Chief Scientific Officer and Head ...

Neurocrine Biosciences, Inc. (NBIX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Neurocrine Biosciences, Inc. ( NBIX) Jefferies London Healthcare Conference 2025 November 18, 2025 7:00 AM EST Hi, everyone. My name is Phoebe Tan, and I am an Associate on Akash Tewari's team. And ...

Jarsking Packaging Highlights The Strategic Advantage of Innovation-Ready Packaging in Canadian Manufacturing

Canadian manufacturing, long stereotyped as focused on resource extraction and commodity production, has pockets of genuine world-class sophistication. In specialized sectors like precision ...